PedAM
Pediatric Disease Annotations & Medicines
| Disease | multiple sclerosis |
| Phenotype | C0033860|psoriasis |
| Sentences | 4 |
| PubMedID- 26203450 | Unfortunately, the patients' cd did not respond to ustekinumab therapy.13 another case report described aggravation of pre-existing psoriasis in a patient with multiple sclerosis during treatment with natalizumab (anti-α4-integrin) treatment.14 vedolizumab is a novel drug that has been fda-approved for the induction and maintenance of remission in patients with uc and cd.5,15 this is a monoclonal antibody that blocks the α4β7 integrin, inhibiting lymphocyte migration from the blood stream and resulting in gut-specific, anti-inflammatory activity. |
| PubMedID- 24839574 | We report the occurrence of arthritis and dactylitis in a multiple sclerosis patient with preexisting psoriasis diagnosed as a psoriatic arthritis. |
| PubMedID- 24576802 | Hla-drb1 15:01 and epstein-barr virus in a multiple sclerosis patient with psoriasis, nasopharyngeal and breast cancers. |
| PubMedID- 26436967 | Successful treatment of psoriasis with ustekinumab in patients with multiple sclerosis. |
Page: 1